Johnson & Johnson’s External Manufacturing Digital Transformation Journey: From COVID-19 disruption to digital collaboration

The COVID-19 pandemic didn't just disrupt pharmaceutical manufacturing—it catalysed a fundamental shift in how we approach CDMO partnerships. Johnson & Johnson's Paolo Giudici reveals how their four-year digital transformation journey is reshaping the future of external manufacturing.

Key transformations reshaping sponsor-CDMO relationships:

• Real-time manufacturing floor visibility enabling proactive process control

• Seamless ERP integration across the partner ecosystem

• Standardised quality data exchange and monitoring

• Compressed timelines from years to months

The critical challenge? Standardisation. Unlike mature industries, pharma lacks unified frameworks for digital CDMO collaboration. "Currently, if a sponsor attempts to establish digital collaboration with a CMO, they essentially start from scratch," notes Giudici.

Strategic implementation insights:

1. Secure explicit partnership agreements before technical integration

2. Focus on value creation, not job displacement

3. Establish clear cost-sharing frameworks upfront

4. Leverage industry collaboration networks

Read the article here

Paolo will be speaking about Digital Transformation of Pharma Manufacturing at CDMO Live 2025. Tickets available now